Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Ibarra

Showing results (1-10 of 153) with videos related to

Pageof 16
Sort By:
Current Drug Discovery Technologies|June 13, 2009
Pharmacological approaches to induce neuroregeneration in spinal cord injury: an overviewAntonio Ibarra, Susana Martiñón
Brain Circulation|October 18, 2019
Microbiota and memory: A symbiotic therapy to counter cognitive decline?Matthew Heyck, Antonio Ibarra
Current Medicinal Chemistry|October 5, 2006
Protective effect of cyclosporin-A in spinal cord injury: an overviewAntonio Ibarra, Araceli Diaz-Ruiz
Clinics and Practice|January 24, 2025
The Critical Management of Spinal Cord Injury: A Narrative ReviewEmilio Moreno-González, Antonio Ibarra
Medical Hypotheses|October 19, 2019
Prebiotics and probiotics as potential therapy for cognitive impairmentAlejandra Romo-Araiza, Antonio Ibarra
Computational Biology and Chemistry|August 7, 2015
Distribution of putative xenogeneic silencers in prokaryote genomesErnesto Perez-Rueda, J Antonio Ibarra
Neuroscience Letters|September 18, 2007
Copolymer-1 (Cop-1) improves neurological recovery after middle cerebral artery occlusion in ratsAntonio Ibarra, Héctor Avendaño, Yolanda Cruz
Cellular Microbiology|September 25, 2009
Salmonella--the ultimate insider. Salmonella virulence factors that modulate intracellular survivalJ Antonio Ibarra, Olivia Steele-Mortimer
Neural Regeneration Research|January 26, 2016
Immunization with Cop-1 promotes neuroprotection and neurogenesis after ischemic strokeYolanda Cruz, Paola Suárez-Meade, Antonio Ibarra
Neural Regeneration Research|January 27, 2017
Spinal cord injury: potential neuroprotective therapy based on neural-derived peptidesElisa García, José Mondragón-Caso, Antonio Ibarra
Pageof 16

Showing results (1-10 of 153) with videos related to

Sort By:
Pageof 16
Current Drug Discovery Technologies|June 13, 2009
Pharmacological approaches to induce neuroregeneration in spinal cord injury: an overviewAntonio Ibarra, Susana Martiñón
Brain Circulation|October 18, 2019
Microbiota and memory: A symbiotic therapy to counter cognitive decline?Matthew Heyck, Antonio Ibarra
Current Medicinal Chemistry|October 5, 2006
Protective effect of cyclosporin-A in spinal cord injury: an overviewAntonio Ibarra, Araceli Diaz-Ruiz
Clinics and Practice|January 24, 2025
The Critical Management of Spinal Cord Injury: A Narrative ReviewEmilio Moreno-González, Antonio Ibarra
Medical Hypotheses|October 19, 2019
Prebiotics and probiotics as potential therapy for cognitive impairmentAlejandra Romo-Araiza, Antonio Ibarra
Computational Biology and Chemistry|August 7, 2015
Distribution of putative xenogeneic silencers in prokaryote genomesErnesto Perez-Rueda, J Antonio Ibarra
Neuroscience Letters|September 18, 2007
Copolymer-1 (Cop-1) improves neurological recovery after middle cerebral artery occlusion in ratsAntonio Ibarra, Héctor Avendaño, Yolanda Cruz
Cellular Microbiology|September 25, 2009
Salmonella--the ultimate insider. Salmonella virulence factors that modulate intracellular survivalJ Antonio Ibarra, Olivia Steele-Mortimer
Neural Regeneration Research|January 26, 2016
Immunization with Cop-1 promotes neuroprotection and neurogenesis after ischemic strokeYolanda Cruz, Paola Suárez-Meade, Antonio Ibarra
Neural Regeneration Research|January 27, 2017
Spinal cord injury: potential neuroprotective therapy based on neural-derived peptidesElisa García, José Mondragón-Caso, Antonio Ibarra
Pageof 16